{"title": "Merck & Co Inc. Archives", "author": null, "url": "https://www.europeanpharmaceuticalreview.com/organisations/merck-co-inc/", "hostname": "europeanpharmaceuticalreview.com", "description": "News stories and articles referencing Merck & Co Inc. on European Pharmaceutical Review", "sitename": "European Pharmaceutical Review", "date": "2023-04-17", "cleaned_text": "Through a $10.8 billion acquisition, Merck has agreed to buy Prometheus Biosciences to advance development of a novel monoclonal antibody for immune conditions. "}